论文部分内容阅读
本文以28例急性发作期COPD病人为对象,观察口服黄芩素胶囊前后动脉血浆中LTC4水平及呼吸功能的改善程度。结果,黄芩素可降低COPD病人动脉血浆中LTC4水平,改善COPD病人呼吸功能。
In this paper, 28 acute exacerbation of COPD patients as the object, observed oral administration of baicalein capsule before and after the level of LTC4 in plasma and respiratory function improvement. As a result, baicalein can reduce the level of LTC4 in the arterial plasma of patients with COPD and improve the respiratory function in COPD patients.